- 5 Resultados
precio mínimo: € 177,42, precio máximo: € 222,91, precio promedio: € 196,64
1
Novel Therapeutic Targets for Antiarrhythmic Drugs - George Edward Billman
Pedir
por lehmanns.de
€ 181,79
Envío: € 0,001
PedirEnlace patrocinado
George Edward Billman:

Novel Therapeutic Targets for Antiarrhythmic Drugs - encuadernado, tapa blanda

2010, ISBN: 9780470261002

Buch, Hardcover, PROFILES POTENTIAL TREATMENT APPROACHES FOR CARDIAC ARRHYTHMIAS Cardiac arrhythmias of ventricular origin are responsible for the deaths of nearly half a million Americ… Más…

Gastos de envío:Lieferbar (Termin unbekannt) (EUR 0.00)
2
Novel Therapeutic Targets for Antiarrhythmic Drugs - Billman, George Edward
Pedir
por amazon.co.uk
£ 187,57
(aprox. € 218,45)
Envío: € 5,591
PedirEnlace patrocinado

Billman, George Edward:

Novel Therapeutic Targets for Antiarrhythmic Drugs - Primera edición

2010, ISBN: 9780470261002

Pasta dura

Wiley, Hardcover, Auflage: 1, 616 Seiten, Publiziert: 2010-01-26T00:00:01Z, Produktgruppe: Book, 0.98 kg, Wiley-Blackwell Medicine & Health Store, Special Features, Books, Books Global St… Más…

Gastos de envío:Les coûts d'expédition peuvent différer des coûts réels. (EUR 5.59)
3
Novel Therapeutic Targets for Antiarrhythmic Drugs - Billman, George Edward
Pedir
por amazon.co.uk
£ 151,79
(aprox. € 177,42)
Envío: € 5,611
PedirEnlace patrocinado
Billman, George Edward:
Novel Therapeutic Targets for Antiarrhythmic Drugs - Primera edición

2010

ISBN: 9780470261002

Pasta dura

Wiley, Hardcover, Auflage: 1, 616 Seiten, Publiziert: 2010-01-26T00:00:01Z, Produktgruppe: Book, 0.98 kg, Wiley-Blackwell Medicine & Health Store, Special Features, Books, Books Global St… Más…

Gastos de envío:In stock. Die angegebenen Versandkosten können von den tatsächlichen Kosten abweichen. (EUR 5.61) rbmbooks
4
Novel Therapeutic Targets for Antiarrhythmic Drugs - Billman, George Edward
Pedir
por amazon.fr
€ 222,91
Envío: € 2,991
PedirEnlace patrocinado
Billman, George Edward:
Novel Therapeutic Targets for Antiarrhythmic Drugs - libro nuevo

2010, ISBN: 9780470261002

Wiley?Blackwell, Relié, 578 Seiten, Publiziert: 2010-01-26T00:00:01Z, Produktgruppe: Livre, 2.16 kg, Livres anglais et étrangers, Boutiques, Livres, Pharmacie, Spécialités médicales, Scie… Más…

Gastos de envío:En stock. Les coûts d'expédition peuvent différer des coûts réels. (EUR 2.99) premium-books-europe
5
Pedir
por alibris.co.uk
€ 182,63
PedirEnlace patrocinado
Ge Billman:
Novel Therapeutic Targets for Antiarrhythmic Drugs - encuadernado, tapa blanda

2001, ISBN: 9780470261002

Hardcover, PLEASE NOTE, WE DO NOT SHIP TO DENMARK. New Book. Shipped from UK in 4 to 14 days. Established seller since 2000. Please note we cannot offer an expedited shipping service from… Más…

Gastos de envío:más gastos de envío Fairford, GLOUCESTERSHIRE, Books2anywhere

1Dado que algunas plataformas no nos comunican las condiciones de envío y éstas pueden depender del país de entrega, del precio de compra, del peso y tamaño del artículo, de una posible membresía a la plataforma, de una entrega directa por parte de la plataforma o a través de un tercero (Marketplace), etc., es posible que los gastos de envío indicados por eurolibro/terralibro no concuerden con los de la plataforma ofertante.

Datos bibliográficos del mejor libro coincidente

Detalles del libro
Novel Therapeutic Targets for Antiarrhythmic Drugs

Profiles potential treatment approaches for cardiac arrhythmias Cardiac arrhythmias of ventricular origin are responsible for the deaths of nearly half a million Americans each year while atrial fibrillation accounts for about 2.3 million cases per year, a rate that is projected to increase 2.5 fold over the next half century. Effectively managing these cardiac rhythm disorders remains a major challenge for both caregivers and the pharmaceutical industry. Filling a gap in the current literature, Novel Therapeutic Targets for Antiarrhythmic Drugs presents the latest treatments for cardiac arrhythmias alongside comprehensive presentations of basic cardiac physiology and pharmacology. Written by leading experts in their research areas, this invaluable resource offers both practitioners and researchers a one-stop guide that brings together previously dispersed information. The text consists of four sections: * Section One comprehensively reviews basic cardiac electrophysiology, the mechanisms responsible for arrhythmias in the setting of ischemia, and basic pharmacology of antiarrhythmic drugs. * Section Two addresses safety pharmacology, including the concept of "repolarization reserve," safety challenges, and regulatory issues for the development of novel antiarrhythmic drugs. * Section Three describes several novel pharmacological targets for antiarrhythmic drugs, including both ion channel and non-ion channel targets. * Section Four describes promising non-pharmacological antiarrhythmic interventions including selective cardiac neural disruption or nerve stimulation, aerobic exercise training, and diet (omega-3 fatty acids). Offering an unparalleled look at the current state and future direction of cardiac arrhythmia treatment, Novel Therapeutic Targets for Antiarrhythmic Drugs provides an important resource to advanced students, working researchers, and busy professionals alike.

Detalles del libro - Novel Therapeutic Targets for Antiarrhythmic Drugs


EAN (ISBN-13): 9780470261002
ISBN (ISBN-10): 0470261005
Tapa dura
Año de publicación: 2010
Editorial: Wiley?Blackwell
578 Páginas
Peso: 0,941 kg
Idioma: eng/Englisch

Libro en la base de datos desde 2011-12-15T08:55:56-06:00 (Mexico City)
Página de detalles modificada por última vez el 2023-08-02T10:44:09-06:00 (Mexico City)
ISBN/EAN: 9780470261002

ISBN - escritura alterna:
0-470-26100-5, 978-0-470-26100-2
Mode alterno de escritura y términos de búsqueda relacionados:
Autor del libro: georg edward, bill george
Título del libro: drugs


Datos del la editorial

Autor: George Edward Billman
Título: Novel Therapeutic Targets for Antiarrhythmic Drugs
Editorial: John Wiley & Sons
578 Páginas
Año de publicación: 2010-01-26
Peso: 0,934 kg
Idioma: Inglés
165,00 € (DE)
No longer receiving updates
164mm x 238mm x 34mm

BB; gebunden; Hardcover, Softcover / Chemie; Medizinische Chemie, Pharmazeutische Chemie; Kardiovaskuläre Erkrankungen; Chemistry; Drug Discovery & Development; Pharmakologie u. Pharmazeutische Medizin; Arzneimittelentwicklung; Antiarrhythmika; Wirkstoffforschung u. -entwicklung; Pharmacology & Pharmaceutical Medicine; Cardiovascular Disease; Medical Science; Chemie; Kardiovaskuläre Erkrankung; Medizin; Wirkstoffforschung u. -entwicklung; Kardiovaskuläre Erkrankungen; Pharmakologie u. Pharmazeutische Medizin

Profiles potential treatment approaches for cardiac arrhythmias Cardiac arrhythmias of ventricular origin are responsible for the deaths of nearly half a million Americans each year while atrial fibrillation accounts for about 2.3 million cases per year, a rate that is projected to increase 2.5 fold over the next half century. Effectively managing these cardiac rhythm disorders remains a major challenge for both caregivers and the pharmaceutical industry. Filling a gap in the current literature, Novel Therapeutic Targets for Antiarrhythmic Drugs presents the latest treatments for cardiac arrhythmias alongside comprehensive presentations of basic cardiac physiology and pharmacology. Written by leading experts in their research areas, this invaluable resource offers both practitioners and researchers a one-stop guide that brings together previously dispersed information. The text consists of four sections: * Section One comprehensively reviews basic cardiac electrophysiology, the mechanisms responsible for arrhythmias in the setting of ischemia, and basic pharmacology of antiarrhythmic drugs. * Section Two addresses safety pharmacology, including the concept of "repolarization reserve," safety challenges, and regulatory issues for the development of novel antiarrhythmic drugs. * Section Three describes several novel pharmacological targets for antiarrhythmic drugs, including both ion channel and non-ion channel targets. * Section Four describes promising non-pharmacological antiarrhythmic interventions including selective cardiac neural disruption or nerve stimulation, aerobic exercise training, and diet (omega-3 fatty acids). Offering an unparalleled look at the current state and future direction of cardiac arrhythmia treatment, Novel Therapeutic Targets for Antiarrhythmic Drugs provides an important resource to advanced students, working researchers, and busy professionals alike.

Más, otros libros, que pueden ser muy parecidos a este:

Último libro similar:
9780470561416 Novel Therapeutic Targets for Antiarrhythmic Drugs (Billman, George Edward)


< para archivar...